Projects funded by the NCN
Neuroprotective effect of SGLT2i: direct influence on amyloid-β related pathology
2023/49/N/NZ7/03566
Keywords:
SGLT2i amyloid-β empaglifloizn canagliflozin dapagliflozin blood-brain barrier
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 208 844 PLN
Project start date (Y-m-d): 2024-01-19
Project end date (Y-m-d): 2027-01-18
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.